|
1
|
Liu S, Chen M, Li P, Wu Y, Chang C, Qiu Y,
Cao L, Liu Z and Jia C: Ginsenoside rh2 inhibits cancer stem-like
cells in skin squamous cell carcinoma. Cell Physiol Biochem.
36:499–508. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ou C, Liu H, Ding Z and Zhou L:
Chloroquine promotes gefitinib-induced apoptosis by inhibiting
protective autophagy in cutaneous squamous cell carcinoma. Mol Med
Rep. 20:4855–4866. 2019.PubMed/NCBI
|
|
3
|
Mei XL and Zhong S: Long noncoding RNA
LINC00520 prevents the progression of cutaneous squamous cell
carcinoma through the inactivation of the PI3K/Akt signaling
pathway by downregulating EGFR. Chin Med J (Engl). 132:454–465.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Toll A, Gimeno-Beltrán J, Ferrandiz-Pulido
C, Masferrer E, Yébenes M, Jucglà A, Abal L, Martí RM, Sanmartín O,
Baró T, et al: D2-40 immunohistochemical overexpression in
cutaneous squamous cell carcinomas: A marker of metastatic risk. J
Am Acad Dermatol. 67:1310–1318. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li Y, Huang C and Yang X: Characterization
of TCF4-mediated oncogenic role in cutaneous squamous cell
carcinoma. Int J Clin Exp Pathol. 12:3583–3594. 2019.PubMed/NCBI
|
|
6
|
Ci C, Wu C, Lyu D, Chang X, He C, Liu W,
Chen L and Ding W: Downregulation of kynureninase restrains
cutaneous squamous cell carcinoma proliferation and represses the
PI3K/AKT pathway. Clin Exp Dermatol. 45:194–201. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Burton KA, Ashack KA and Khachemoune A:
Cutaneous squamous cell carcinoma: A review of high-risk and
metastatic disease. Am J Clin Dermatol. 17:491–508. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zilberg C, Lee MW, Kraitsek S, Ashford B,
Ranson M, Shannon K, Iyer NG, Ch'ng S, Low TH, Palme C, et al: Is
high-risk cutaneous squamous cell carcinoma of the head and neck a
suitable candidate for current targeted therapies? J Clin Pathol.
73:17–22. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Uszczynska-Ratajczak B, Lagarde J,
Frankish A, Guigo R and Johnson R: Towards a complete map of the
human long non-coding RNA transcriptome. Nat Rev Genet. 19:535–548.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shi D, Zhang C and Liu X: Long noncoding
RNAs in cervical cancer. J Cancer Res Ther. 14:745–753. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hosseini ES, Meryet-Figuiere M,
Sabzalipoor H, Kashani HH, Nikzad H and Asemi Z: Dysregulated
expression of long noncoding RNAs in gynecologic cancers. Mol
Cancer. 16:1072017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen L, Yao H, Wang K and Liu X: Long
Non-coding RNA MALAT1 regulates ZEB1 expression by sponging
miR-143-3p and promotes hepatocellular carcinoma progression. J
Cell Biochem. 118:4836–4843. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Y, Fu L, Sun A, Tang D, Xu Y, Li Z,
Chen M and Zhang G: C/EBPβ contributes to transcriptional
activation of long non-coding RNA NEAT1 during APL cell
differentiation. Biochem Biophys Res Commun. 499:99–104. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Anastasiadou E, Jacob LS and Slack FJ:
Non-coding RNA networks in cancer. Nat Rev Cancer. 18:5–18. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu Z, Wang N, Wang F, Zhang S and Ding J:
Silencing of lncRNA EZR-AS1 inhibits proliferation, invasion, and
migration of colorectal cancer cells through blocking transforming
growth factor β signaling. Biosci Rep. 39:BSR201911992019.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
You G, Long X, Song F, Huang J, Tian M,
Xiao Y, Deng S and Wu Q: Long noncoding RNA EZR-AS1 regulates the
proliferation, migration, and apoptosis of human venous endothelial
cells via SMYD3. Biomed Res Int. 2020:68402342020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ghaffari A, Hoskin V, Turashvili G, et al:
Intravital imaging reveals systemic ezrin inhibition impedes cancer
cell migration and lymph node metastasis in breast cancer. Breast
Cancer Res. 21:122019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xie JJ, Xu LY, Wu ZY, Zhao Q, Xu XE, Wu
JY, Huang Q and Li EM: Prognostic implication of ezrin expression
in esophageal squamous cell carcinoma. J Surg Oncol. 104:538–543.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xie YH, Li LY, He JZ, Xu XE, Liao LD,
Zhang Q, Xie JJ, Xu LY and Li EM: Heat shock protein family B
member 1 facilitates ezrin activation to control cell migration in
esophageal squamous cell carcinoma. Int J Biochem Cell Biol.
112:79–87. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bai Y, Zhou X, Huang L, Wan Y, Li X and
Wang Y: Long noncoding RNA EZR-AS1 promotes tumor growth and
metastasis by modulating Wnt/β-catenin pathway in breast cancer.
Exp Thera Med. 16:2235–2242. 2018.
|
|
21
|
Zhang XD, Huang GW, Xie YH, He JZ, Guo JC,
Xu XE, Liao LD, Xie YM, Song YM, Li EM and Xu LY: The interaction
of lncRNA EZR-AS1 with SMYD3 maintains overexpression of EZR in
ESCC cells. Nucleic Acids Res. 46:1793–1809. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Polivka J Jr and Janku F: Molecular
targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol
Ther. 142:164–175. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gou XJ, Bai HH, Liu LW, Chen HY, Shi Q,
Chang LS, Ding MM, Shi Q, Zhou MX, Chen WL and Zhang LM: Asiatic
acid interferes with invasion and proliferation of breast cancer
cells by inhibiting WAVE3 activation through PI3K/AKT signaling
pathway. Biomed Res Int. 2020:18743872020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li C, Qin Y, Zhong Y, Qin Y, Wei Y, Li L
and Xie Y: Fentanyl inhibits the progression of gastric cancer
through the suppression of MMP-9 via the PI3K/Akt signaling
pathway. Ann Transl Med. 8:1182020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Troiano A, Lomoriello IS, di Martino O,
Fusco S, Pollice A, Vivo M, La Mantia G and Calabro V: Y-box
binding protein-1 is part of a complex molecular network linking
ΔNp63α to the PI3K/akt pathway in cutaneous squamous cell
carcinoma. J Cell Physiol. 230:2067–2074. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cao Z, Pan X, Yang Y, Huang Y and Shen HB:
The lncLocator: A subcellular localization predictor for long
non-coding RNAs based on a stacked ensemble classifier.
Bioinformatics. 34:2185–2194. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li X, Bao C, Ma Z, Xu B, Ying X, Liu X and
Zhang X: Perfluorooctanoic acid stimulates ovarian cancer cell
migration, invasion via ERK/NF-κB/MMP-2/-9 pathway. Toxicol Lett.
294:44–50. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jarskog LF, Selinger ES, Lieberman JA and
Gilmore JH: Apoptotic proteins in the temporal cortex in
schizophrenia: High Bax/Bcl-2 ratio without caspase-3 activation.
Am J Psychiatry. 161:109–115. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sathe A and Nawroth R: Targeting the
PI3K/AKT/mTOR pathway in bladder cancer. Methods Mol Biol.
1655:335–350. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang SL, Ma L, Zhao J, You SP, Ma XT, Ye
XY and Liu T: The phenylethanol glycoside liposome inhibits
PDGF-induced HSC activation via regulation of the FAK/PI3K/Akt
signaling pathway. Molecules. 24:32822019. View Article : Google Scholar
|
|
32
|
Duan H, Li X, Chen Y, Wang Y and Li Z:
LncRNA RHPN1-AS1 promoted cell proliferation, invasion and
migration in cervical cancer via the modulation of miR-299-3p/FGF2
axis. Life Sci. 239:1168562019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liao CL, Chu YL, Lin HY, Chen CY, Hsu MJ,
Liu KC, Lai KC, Huang AC and Chung JG: Bisdemethoxycurcumin
suppresses migration and invasion of human cervical cancer HeLa
cells via inhibition of NF-kB, MMP-2 and −9 pathways. Anticancer
Res. 38:3989–3997. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rasool M, Malik A, Basit Ashraf MA,
Parveen G, Iqbal S, Ali I, Qazi MH, Asif M, Kamran K, Iqbal A, et
al: Evaluation of matrix metalloproteinases, cytokines and their
potential role in the development of ovarian cancer. PLoS One.
11:e01671492016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li X, Yang Z, Song W, et al:
Overexpression of Bmi-1 contributes to the invasion and metastasis
of hepatocellular carcinoma by increasing the expression of matrix
metalloproteinase (MMP)-2, MMP-9 and vascular endothelial growth
factor via the PTEN/PI3K/Akt pathway. Int J Oncol. 43:793–802.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pistritto G, Trisciuoglio D, Ceci C,
Garufi A and D'Orazi G: Apoptosis as anticancer mechanism: Function
and dysfunction of its modulators and targeted therapeutic
strategies. Aging (Albany NY). 8:603–619. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhu F, Jiang D, Zhang M and Zhao B:
2,4-Dihydroxy-3′-methoxy-4′-ethoxychalcone suppresses cell
proliferation and induces apoptosis of multiple myeloma via the
PI3K/akt/mTOR signaling pathway. Pharm Biol. 57:641–648. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sanz Ressel BL, Massone AR and Barbeito
CG: Immunohistochemical expression of selected phosphoproteins of
the mTOR signalling pathway in canine cutaneous squamous cell
carcinoma. Vet J. 245:41–48. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wu XY, Tian F, Su MH, Wu M, Huang Y, Hu
LH, Jin L and Zhu XJ: BF211, a derivative of bufalin, enhances the
cytocidal effects in multiple myeloma cells by inhibiting the
IL-6/JAK2/STAT3 pathway. Int Immunopharmacol. 64:24–32. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yao M, Shang YY, Zhou ZW, Yang YX, Wu YS,
Guan LF, Wang XY, Zhou SF and Wei X: The research on lapatinib in
autophagy, cell cycle arrest and epithelial to mesenchymal
transition via Wnt/ErK/PI3K-AKT signaling pathway in human
cutaneous squamous cell carcinoma. J Cancer. 8:220–226. 2017.
View Article : Google Scholar : PubMed/NCBI
|
